z-logo
Premium
Structural studies of protein arginine methyltransferase 2 reveal its interactions with potential substrates and inhibitors
Author(s) -
Cura Vincent,
Marechal Nils,
TrofferCharlier Nathalie,
Strub JeanMarc,
Haren Matthijs J.,
Martin Nathaniel I.,
Cianférani Sarah,
Bonnefond Luc,
Cavarelli Jean
Publication year - 2017
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/febs.13953
Subject(s) - methylation , biology , microbiology and biotechnology , biochemistry , gene
PRMT 2 is the less‐characterized member of the protein arginine methyltransferase family in terms of structure, activity, and cellular functions. PRMT 2 is a modular protein containing a catalytic Ado‐Met‐binding domain and unique Src homology 3 domain that binds proteins with proline‐rich motifs. PRMT 2 is involved in a variety of cellular processes and has diverse roles in transcriptional regulation through different mechanisms depending on its binding partners. PRMT 2 has been demonstrated to have weak methyltransferase activity on a histone H4 substrate, but its optimal substrates have not yet been identified. To obtain insights into the function and activity of PRMT 2, we solve several crystal structures of PRMT 2 from two homologs (zebrafish and mouse) in complex with either the methylation product S‐adenosyl‐L‐homocysteine or other compounds including the first synthetic PRMT 2 inhibitor (Cp1) studied so far. We reveal that the N‐terminal‐containing SH 3 module is disordered in the full‐length crystal structures, and highlights idiosyncratic features of the PRMT 2 active site. We identify a new nonhistone protein substrate belonging to the serine‐/arginine‐rich protein family which interacts with PRMT 2 and we characterize six methylation sites by mass spectrometry. To better understand structural basis for Cp1 binding, we also solve the structure of the complex PRMT 4:Cp1. We compare the inhibitor–protein interactions occurring in the PRMT 2 and PRMT 4 complex crystal structures and show that this compound inhibits efficiently PRMT 2. These results are a first step toward a better understanding of PRMT 2 substrate recognition and may accelerate the development of structure‐based drug design of PRMT 2 inhibitors. Database All coordinates and structure factors have been deposited in the Protein Data Bank: zPRMT2 1‐408 ‐SFG = 5g02 ; zPRMT2 73‐408 ‐SAH = 5fub ; mPRMT2 1‐445 ‐SAH = 5ful ; mPRMT2 1‐445 ‐Cp1 = 5fwa , mCARM1 130‐487 ‐Cp1 = 5k8v .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom